The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.

There is a now a wealth of epidemiological, animal, and clinical data to suggest the benefits of uric acid reduction and hxanthine oxidase inhibition in prevention of vascular disease. This review discusses the available epidemiological, preclinical, and clinical data and considers arguments for and against a role for serum uric acid in common cardiovascular disorders. It concludes that large scale trials with clinical endpoints are justified to address this important question and to define whether use of drugs such as allopurinol should be a routine part of preventative strategies.

Citation

Peter Higgins, Jesse Dawson, Matthew Walters. The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease. Cardiovascular psychiatry and neurology. 2009;2009:282059

PMID: 20029618

search → result